Gentao Fan

305 Zhongshan East Road
Nanjing, 210002, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Anti-PD-1 antibody plus anlotinib vs. anlotinib alone in patients with refractory chondrosarcoma: A multicenter, non-randomized phase 2 FLAIL-C trial.

Anti-PD-1 antibody plus anlotinib vs. anlotinib alone in patients with refractory chondrosarcoma: A multicenter, non-randomized phase 2 FLAIL-C trial.

Journal: Med (New York, N.Y.)
Published: June 05, 2025

Biomimetic Fabrication and Osteogenic Effects of E7BMP-2 Peptide Coassembly Microspheres Based α-Tricalcium Phosphate with Silk Fibroin.

Biomimetic Fabrication and Osteogenic Effects of E7BMP-2 Peptide Coassembly Microspheres Based α-Tricalcium Phosphate with Silk Fibroin.

Journal: ACS applied bio materials
Published: February 13, 2025

Research progress of circRNAs in bone-related diseases.

Research progress of circRNAs in bone-related diseases.

Journal: Frontiers in oncology
Published: September 06, 2024

Retraction Note: LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p.

Retraction Note: LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p.

Journal: BMC cancer
Published: November 18, 2023

FRS2 regulated by miR-429 and miR-206 promotes angiogenesis in osteosarcoma.

FRS2 regulated by miR-429 and miR-206 promotes angiogenesis in osteosarcoma.

Journal: Gene
Published: October 09, 2023

Circular RNA CircSATB2 facilitates osteosarcoma progression through regulating the miR-661/FUS-mediated mRNA of ZNFX1.

Circular RNA CircSATB2 facilitates osteosarcoma progression through regulating the miR-661/FUS-mediated mRNA of ZNFX1.

Journal: Cellular signalling
Published: July 13, 2023

In vivo self-assembly and delivery of VEGFR2 siRNA-encapsulated small extracellular vesicles for lung metastatic osteosarcoma therapy.

In vivo self-assembly and delivery of VEGFR2 siRNA-encapsulated small extracellular vesicles for lung metastatic osteosarcoma therapy.

Journal: Cell death & disease
Published: February 02, 2023

Covalent immobilization of VEGF on allogeneic bone through polydopamine coating to improve bone regeneration.

Covalent immobilization of VEGF on allogeneic bone through polydopamine coating to improve bone regeneration.

Journal: Frontiers in bioengineering and biotechnology
Published: July 26, 2022

PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma.

PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma.

Journal: Frontiers in oncology
Published: June 29, 2022

Identification of RALA as a Therapeutic Target and Prognostic Predictor of Osteosarcoma.

Identification of RALA as a Therapeutic Target and Prognostic Predictor of Osteosarcoma.

Journal: BioMed research international
Published: June 22, 2022

Circular RNA circFIRRE drives osteosarcoma progression and metastasis through tumorigenic-angiogenic coupling.

Circular RNA circFIRRE drives osteosarcoma progression and metastasis through tumorigenic-angiogenic coupling.

Journal: Molecular cancer
Published: April 30, 2022

LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p.

LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p.

Journal: BMC cancer
Published: February 14, 2022
Showing 1-12 of 21

Last Updated: 09/26/2026